These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36703892)

  • 1. Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series.
    Cowan TL; Huang C; Murrell DF
    Front Med (Lausanne); 2022; 9():1117176. PubMed ID: 36703892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome measures for autoimmune blistering diseases.
    Zhao CY; Murrell DF
    J Dermatol; 2015 Jan; 42(1):31-6. PubMed ID: 25558950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review.
    Zeng FAP; Wilson A; Sheriff T; Murrell DF
    JAAD Int; 2022 Dec; 9():33-43. PubMed ID: 36089938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune bullous disease in skin of color: A case series.
    Tamazian S; Simpson CL
    JAAD Case Rep; 2020 Nov; 6(11):1173-1178. PubMed ID: 33145386
    [No Abstract]   [Full Text] [Related]  

  • 6. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of case-control studies on the risk factors for the development of autoimmune blistering diseases.
    Oh DD; Zhao CY; Murrell DF
    J Eur Acad Dermatol Venereol; 2016 Apr; 30(4):595-603. PubMed ID: 26434420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study.
    Xie D; Bilgic A; Abu Alrub N; Dicle Ö; Murrell DF
    JAAD Int; 2023 Mar; 10():6-13. PubMed ID: 36387063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Clinical Trials in Pemphigus and Pemphigoid.
    Izumi K; Bieber K; Ludwig RJ
    Front Immunol; 2019; 10():978. PubMed ID: 31130959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatomyositis in patients with autoimmune blistering diseases.
    Patsatsi A; Pearson DR; Werth VP
    Int J Womens Dermatol; 2019 Sep; 5(4):256-260. PubMed ID: 31700982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases.
    Ohata C; Ishii N; Koga H; Fukuda S; Tateishi C; Tsuruta D; Furumura M; Hashimoto T
    J Am Acad Dermatol; 2015 Jul; 73(1):50-5. PubMed ID: 25896671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
    Alpsoy E; Akman-Karakas A; Uzun S
    Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunogenetics of Autoimmune Blistering Diseases.
    Kneiber D; Kowalski EH; Amber KT
    Adv Exp Med Biol; 2022; 1367():173-212. PubMed ID: 35286697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based review.
    Kang M; Bilgic A; Radjenovic M; Murrell DF
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2745-2756. PubMed ID: 32124493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review.
    Wan V; Chen D; Shiau CJ; Jung GW
    SAGE Open Med Case Rep; 2022; 10():2050313X221131868. PubMed ID: 36274858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological therapy of autoimmune blistering diseases.
    Alaibac M
    Expert Opin Biol Ther; 2019 Feb; 19(2):149-156. PubMed ID: 30558452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.
    Iwata H; Bieber K; Hirose M; Ludwig RJ
    Curr Pharm Des; 2015; 21(18):2422-39. PubMed ID: 25777758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.